Read More 1 minute read Analyst Ratings News Price Target Reiteration Piper Sandler Reiterates Overweight on Matterport, Maintains $4 Price Target By richadhand@benzinga.com March 21, 8:25 AM Piper Sandler analyst Brent Bracelin reiterates Matterport (NASDAQ:MTTR) with a Overweight and maintains $4 price target. MTTR
Read More 1 minute read Analyst Color Analyst Ratings General News Penny Stocks Price Target Reiteration There Is Some Light At The End Of The Tunnel – Here’s Why Analyst Remains Bullish On This Beauty Company By Shivani Kumaresan March 20, 2:29 PM Truist Securities analyst Bill Chappell reiterated a Buy rating on the shares of Olaplex Holdings, Inc. (NASDAQ:OLPX) with a price target of… OLPX
Read More 1 minute read Analyst Color Analyst Ratings General News Price Target Reiteration Hershey’s Raising The Bar? – This Analyst Thinks Shares As Fairly Valued Ahead Of Investor Day By Shivani Kumaresan March 20, 12:31 PM Morgan Stanley analyst Pamela Kaufman reiterated an Equal-Weight rating on the shares of Hershey Co (NYSE:HSY) with a price target of $246.… HSY
Read More 1 minute read Analyst Color Analyst Ratings General Health Care Movers Price Target Reiteration Trading Ideas Analyst Boosts Immunovant Price Target After Updated Pipeline Realignment By Vandana Singh March 20, 12:12 PM HC Wainwright has increased the price target on Immunovant Inc (NASDAQ:IMVT) and reiterates a Buy rating. The analyst says it has updated… ARGX
Read More 1 minute read Analyst Ratings News Price Target Reiteration Small Cap Consumer Research Reiterates Buy on Express, Maintains $5.5 Price Target By Benzinga Newsdesk March 20, 11:54 AM Small Cap Consumer Research analyst Eric Beder reiterates Express (NYSE:EXPR) with a Buy and maintains $5.5 price target. EXPR
Read More 1 minute read Analyst Ratings News Price Target Reiteration Aegis Capital Reiterates Buy on GigaCloud Tech, Maintains $26 Price Target By Benzinga Newsdesk March 20, 11:50 AM Aegis Capital analyst Rommel Dionisio reiterates GigaCloud Tech (NASDAQ:GCT) with a Buy and maintains $26 price target. GCT
Read More 1 minute read Analyst Color Analyst Ratings Biotech General Health Care Large Cap News Reiteration Analyst Writes Incyte’s Opzelura Provides Deepening, Relapse Prevention; Povo Data Intriguing In Depigmented Skin Disorder By Vandana Singh March 20, 10:40 AM Incyte Corporation (NASDAQ:INCY) announced new data from a Phase 2b trial of povorcitinib (INCB54707), an investigational oral JAK1 inhibitor, in adult… INCY
Read More 1 minute read Analyst Ratings News Price Target Reiteration Chardan Capital Reiterates Buy on PLBY Group, Maintains $5 Price Target By Benzinga Newsdesk March 20, 9:49 AM Chardan Capital analyst Brian Dobson reiterates PLBY Group (NASDAQ:PLBY) with a Buy and maintains $5 price target. PLBY
Read More 1 minute read Analyst Ratings News Price Target Reiteration B. Riley Securities Reiterates Neutral on Orion Gr Hldgs, Maintains $3 Price Target By Benzinga Newsdesk March 20, 9:33 AM B. Riley Securities analyst Alex Rygiel reiterates Orion Gr Hldgs (NYSE:ORN) with a Neutral and maintains $3 price target. ORN
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Trade Desk, Maintains $68 Price Target By Benzinga Newsdesk March 20, 8:58 AM Needham analyst Laura Martin reiterates Trade Desk (NASDAQ:TTD) with a Buy and maintains $68 price target. TTD